Effect of Guided Imagery on Well-being in Patients With Multiple Scler
Effect of Guided Imagery on Well-being in Patients With Multiple Sclerosis
What it found
We found no results in the registry or in papers.
This trial finished 9 years ago. We found no results in the registry or in any paper that cites it.
What was tested
Treatment tested
- Guided Imagery
Compared with
- Journaling
What it measured
Main measures
Quality of Life (MS-QOL-54)
Change from baseline at 10 weeks
Quality of life (reported by participants)
Other measures (2)
Mood (BDI-II)
Change from baseline at 10 weeks
Mood and sleepFatigue (FSS)
Change from baseline at 10 weeks
Fatigue
Who could take part
Relapsing MS
Show the full criteria
Inclusion criteria
1. Diagnosis of Relapsing-Remitting Multiple Sclerosis 2. 18-70 years old 3. Able to read and write in English 4. Able to attend sessions at the UC San Diego School of Medicine * Age group: adult * Gender: both * Target enrollment: 20 Participant exclusion criteria: 1. Severe depression (score of 31 or higher on the BDI) 2. Very high levels of fatigue (above an average of 6 on the FSS) 3. Low levels of mindfulness (below an average score of 2 on the FMI).
Exclusion criteria
Not separately supplied in the registry.
As registered. Criteria can change, so ask the trial team or your neurologist.
About this trial
In the sponsor's words
This single-center interventional study quasi-randomly allocated patients to a guided imagery or control intervention (positive journaling). Data were analyzed with treatment allocation masked.
Loading reviews and guidelines…
History
Started
Mar 2012
Main results due
Mar 2017
Finished
Mar 2017